Relay Therapeutics (RLAY)
(Real Time Quote from BATS)
$7.65 USD
-0.34 (-4.26%)
Updated Aug 2, 2024 02:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Cash flow Statements
Fiscal Year End for Relay Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -341.97 | -290.51 | -363.87 | -52.41 | -75.31 |
Depreciation/Amortization & Depletion | -5.49 | 5.31 | 5.98 | 3.13 | 0.35 |
Net Change from Assets/Liabilities | -32.46 | 11.25 | 97.34 | -85.17 | 4.31 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 79.61 | 44.46 | 186.15 | 31.96 | 4.51 |
Net Cash From Operating Activities | -300.32 | -229.49 | -74.41 | -102.49 | -66.13 |
Property & Equipment | -4.13 | -9.06 | -3.47 | -1.93 | -7.98 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | -25.30 | 0.00 | 0.00 |
Investments | 261.76 | -179.68 | -450.74 | 83.60 | -311.04 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 257.63 | -188.75 | -479.51 | 81.67 | -319.02 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 34.75 | 289.91 | 388.09 | 429.02 | 5.61 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | -2.51 | 0.00 |
Net Cash from Financing Activities | 34.75 | 289.91 | 388.09 | 426.51 | 5.61 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -7.93 | -128.33 | -165.83 | 405.69 | -379.55 |
Cash at Beginning of Period | 154.37 | 282.70 | 448.52 | 42.83 | 422.38 |
Cash at End of Period | 146.44 | 154.37 | 282.70 | 448.52 | 42.83 |
Diluted Net EPS | -2.79 | -2.59 | -3.82 | -5.40 | NA |
Fiscal Year End for Relay Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -81.39 | -341.97 | -258.48 | -192.74 |
Depreciation/Amortization & Depletion | NA | -2.27 | -5.49 | -3.20 | -1.69 |
Net Change from Assets/Liabilities | NA | 7.98 | -32.46 | -11.86 | 16.93 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 25.36 | 79.61 | 62.41 | 41.77 |
Net Cash From Operating Activities | NA | -50.32 | -300.32 | -211.13 | -135.73 |
Property & Equipment | NA | -1.78 | -4.13 | -4.01 | -3.42 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 12.31 | 261.76 | 201.96 | 130.01 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | 10.53 | 257.63 | 197.96 | 126.59 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 48.92 | 34.75 | 12.84 | 3.38 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 48.92 | 34.75 | 12.84 | 3.38 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | 9.13 | -7.93 | -0.34 | -5.76 |
Cash at Beginning of Period | NA | 146.44 | 154.37 | 154.37 | 154.37 |
Cash at End of Period | NA | 155.57 | 146.44 | 154.04 | 148.61 |
Diluted Net EPS | NA | -0.62 | -0.66 | -0.54 | -0.81 |